March 12, 2024 News by Margarida Maia, PhD Comorbidities common in MS patients in clinical trials, study finds Nearly half of all multiple sclerosis (MS) patients who participated in clinical trials ā including global, pivotal studies ā had one or more comorbidities, or coexisting conditions, the most common being depression and high blood pressure, a meta-analysis study found. While the rate of patients with comorbidities “may be…
September 22, 2023 Columns by John Connor A quiet MS week that’s just too darned loud to think Big breath, for my travails below necessitate a catch-up on my story so far. For once, my multiple sclerosis and the myriad joyous comorbidities itās conferred on me āĀ trigeminal neuralgia, lymphedema, diplopia, spasticity ā have given me a break. So have the fellow travelers who’ve…
August 25, 2023 Columns by John Connor The itch that turned into an outbreak of yet another comorbidity It’s a new week, so itās time for a new comorbidity. Not content with affecting my brain, spine, and bodily functions, secondary progressive multiple sclerosis is now making my body break down at a cellular level. Make something funny out of that, Connor. Toughie, this one. Maybe later ā…
August 4, 2023 Columns by John Connor MS comorbidities make me a stranger in a strange body I was never a hypochondriac until multiple sclerosis (MS) whacked me. A catastrophic fall while playing tennis in 2007 resulted in a shoulder separation that took two operations to fix. The pain was so bad that, at the time, MS was just something else I had. To be accurate,…
June 2, 2023 Columns by John Connor Up at 9, in bed by 8, yet still no time? My sleep schedule, according to mathematics, leaves me 11 hours ā so whatās my problem? My current ultra-efficient carers arrive at 9:30 a.m. and usually get me into the wet room 15 minutes later. Maybe 20 if my bottom has been misbehaving. Itās been something of a miscreant ever since…
December 26, 2022 News by Margarida Maia, PhD MS Comorbidities Lead to Economic Burden for Patients, Study Finds About half of all individuals diagnosed with multiple sclerosis (MS) have at least one other co-occurring medical disorder, and such comorbidities add a significant economic burden for MS patients in managing their condition, according to an Italian study. These added costs result from an increase in the use of…
August 12, 2022 Columns by John Connor Seeing Double, and Iām Not Even Drunk! I only had my glasses for two years, yet reading anything on my phone was now nigh impossible. Still, it did cure my Facebook and Twitter addiction. Yer, yer, Iām old. (Iām 64, you know.) Sure, Iāve written this before ā surely thatās a free pass for us aged folk.
June 13, 2022 News by Marisa Wexler, MS MS Tied to 75% Increased Risk of Mortality in US Study The overall risk of death is about 75% higher for people with multiple sclerosis (MS) than in the general population, according to a new study. “The association was independent of demographic, socioeconomic variables, lifestyle factors, baseline diabetes, cardiovascular disease, chronic respiratory disease, and cancer status,” researchers wrote. The study,…
January 13, 2022 News by Lindsey Shapiro, PhD MS Type, Anti-CD20 Therapies Tied to Higher COVID-19 Mortality Risk Among people with multiple sclerosis (MS), a progressive disease type and the use of anti-CD20 therapies ā such as ocrelizumab and rituximab ā were associated with an increased risk of death from COVID-19, a new meta-analysis revealed. āWe hope that these findings ā¦ may help neurologists in optimizing…
September 13, 2021 News by Somi Igbene, PhD Health Status of Immigrants With MS Complex, Canadian Study Finds A number of health conditions ā including high blood pressure, migraines, schizophrenia, and rheumatoid arthritis ā are more common among immigrants to Canada who haveĀ multiple sclerosis (MS) than those without MS, an observational study reported. Compared with long-term residents with MS, immigrants with this disease were less likely to…
February 25, 2021 News by Marisa Wexler, MS #ACTRIMS2021 – Better Strategies Needed to Help Socioeconomically Disadvantaged Patients Editor’s note: TheĀ Multiple Sclerosis News Today news team is providing in-depth and unparalleled coverage of the virtual ACTRIMS Forum 2021, Feb. 25-27. Go here to see all the latest stories from the conference. People with multiple sclerosis (MS) who are less socioeconomically advantaged tend to have faster rates…
September 28, 2020 News by Teresa Carvalho, MS High Co-occurrence of Psychiatric, Cardiovascular Diseases in MS, Study Reports People with multiple sclerosis (MS) show a high occurrence of comorbidities ā two diseases occurring in one person at the same time ā with psychiatric and cardiovascular diseases being the most common, a new study reports. Having another co-existing disorder was found to have an impact on MS…
August 14, 2020 News by Forest Ray PhD 35% of Newly Diagnosed Patients Given DMT in Follow-up Years, US Study Finds Almost two-thirds of people newly diagnosed with multiple sclerosis (MS) in the United States, identified through a national database, were not prescribed disease-modifying therapies (DMTs) over an average of more than two years of follow-up, a real-world study of nearly 5,700 patients found. Current guidelines “recommend early treatment with…
July 16, 2020 Columns by Jennifer (Jenn) Powell Accepting a New Diagnosis I have long preached the merits of acceptance. In embracing my MS, I have mitigated much of the accompanying fear. This modus operandi has enabled me to live alongside my disease as opposed to clashing with it. While ideal, it is becoming increasingly difficult to follow my advice. Two…
July 1, 2020 News by Steve Bryson, PhD Anxiety and Depression Linked to RRMS Relapse Risk, Study Finds Comorbidities such as anxiety and depression are associated with a significantly increased risk of relapse in people with relapsing-remitting multiple sclerosis (RRMS), a clinical trial analysis has found.Ā Anxiety and abnormal blood lipids (fats) also increased the risk of any RRMS disease activity.Ā Based on those findings, researchers…
February 5, 2020 News by Vanessa Pataia Having Other Health Conditions Does Not Raise Risk of MS-related Hospitalization, Study Finds Having other health conditions, or comorbidities, along with multiple sclerosis (MS) does not increase a person’s risk of being hospitalized due to MS-specific symptoms, although it does raise the rate of all-cause hospital admissions, a study found.Ā The finding was described…
September 26, 2019 Columns by Tamara Sellman Need to Know: What Is an MS Mimic? Editor’s note: “Need to Knowā is a series inspired by common forum questions and comments from readers. Have a comment or question about MS? Visit our forum. This week’s question is inspired by the forum topicĀ “Is it an MS Diagnosis or is it something else? ” from July…
September 11, 2019 News by Patricia Inacio, PhD #ECTRIMS2019 – Real-world Data Supports Serum Neurofilament Light as Potential MS Biomarker Serum neurofilament light chain (sNfL) in the blood ā a proposed biomarker for multiple sclerosis (MS) ā is linked with worse neurologic function at levels above a certain threshold, according to data from a large, real-world study. Kathryn Fitzgerald, assistant professor at the Johns Hopkins School of…
March 1, 2019 News by Jonathan Grinstein #ACTRIMS2019 ā Health-related Quality of Life in MS Patients Linked to Comorbidities There is a need for better diagnosis and treatment management of comorbidities ā simultaneously occurring disorders ā in people with multiple sclerosis (MS), as shown by the impact these additional health issues have on patientsā health-related quality of life, according to a new report. The data was presented by Lara…
February 1, 2019 News by Jonathan Grinstein Medication Use in RRMS Patients Highlights Importance of Better Treatment Management, Study Says Patients with relapsing-remitting multiple sclerosis, particularly those with multiple conditions who are more severely disabled, are more likely to be using several medications at the same time, a study shows. These findings highlight the need for physicians to be aware of what medications their patients are taking to avoid…
December 14, 2018 Columns by John Connor Betwixt and Between Usually, I have an idea of what I’m going to write. Today, all I feel is a bit meeeeughĀ … Which is more a sound of ennui than a recognizable word. In these days of multimedia, I suppose I should record it and insert the clip into the text, but…
July 23, 2018 News by Iqra Mumal, MSc Hypertension More Common in MS Patients Than General Public, Study Reports People with multiple sclerosis are 48 percent more likely to have high blood pressure compared to the general population ā and to people with other demyelinating diseases, a new study reports. Its researchers also emphasize that hypertension is already linked to poorer outcomes in MS patients. The study, āCardiovascular…
June 13, 2018 Columns by Cathy Chester Multiple Sclerosis, Comorbidities, and How to Live with Them Iām doing all I can to remain calm and keep stressors at bay all in the name of wellness. So Iām trying to meditate at least five minutes a day ā find a quiet room to sit tall, close my eyes, and focus on my…
February 27, 2018 News by Iqra Mumal, MSc Comorbidities Among MS Patients in US Range from High Cholesterol and Blood Pressure to Anxiety, Study Reports Comobidities are common in multiple sclerosis (MS) patients in the U.S., with the mostĀ frequent being high cholesterolĀ and blood pressure, followed by gastrointestinal disease, thyroid disease, and anxiety, a database analysis reports. But distinctions exist between the sexes, this claims analysis found. High cholesterol and blood pressure, as well as diabetes…
December 19, 2017 News by Patricia Inacio, PhD Additional Diseases Increase Risk of MS Relapses, Canadian Study Shows Multiple sclerosis patients with additional diseases, high cholesterol levels or a history of migraine headaches are more likely to experience relapses than other patients, a Canadian study shows. The report, āComorbidity increases the risk of relapse in multiple sclerosis,ā was published in the journal Neurology. Researchers…
June 22, 2016 News by InĆŖs Martins, PhD Fatigue That Troubles MS Patients Linked to Other Ills Stemming from the Disease Fatigue, the most commonly reported symptom in patients with multiple sclerosis (MS), is associated with diseaseĀ comorbidities such as depression, irritable bowel syndrome, migraine, and anxiety, according to the study “Fatigue and Comorbidities in Multiple Sclerosis,” recently published in the International Journal of MS Care.
March 7, 2016 News by Patricia Silva, PhD New Study Explores Brain Damage in MS Patients with Autoimmune Comorbidities People with multiple sclerosis (MS) who also suffer from other autoimmune conditions, like thyroid disease orĀ diabetes, have more severeĀ brain damage than MS patients without comorbidities, according to a study fromĀ theĀ University at Buffalo. The study wasĀ recently published in the American Journal of Neuroradiology. An earlier report from…
January 13, 2016 News by Margarida Azevedo, MSc MS Patients Treated in Clinical Practice with Fingolimod Show Benefits New research evaluating fingolimodās clinical efficacy, safety, and tolerability in patients with relapsing-remitting multiple sclerosis (RRMS) largely supported its use, finding that the oral drugās efficacy in a real-world settingĀ was comparable to results observed in Phase 3Ā clinical studies. The research article, āEfficacy and Safety of Fingolimod in an Unselected…
September 8, 2014 News by Maureen Newman Comorbidities More Prevalent With Multiple Sclerosis Diagnosis While multiple sclerosis is most typically associated with progressively declining physical ability, multiple sclerosis patients are often times affected by a number of physical and mental health comorbidities in addition to their worsening physical ability. This observation was highlighted by a group of researchers in Scotland led by Drs.